Pharmaceutical Technology

MAY 19, 2023

While MS is not a terminal diagnosis, the effect of the disease on the CNS can significantly impact patients’ independence and disturb their daily lives. However, they cannot provide a cure and have a very limited impact on halting disease progression. DMTs for MS have a high price tag, particularly in the US.

98

98

Pharmaceutical Technology

APRIL 13, 2023

Two gene therapies up for approval this year for sickle cell disease could be cost effective in some cases at a $2 million price point, based on a draft evidence report published by the Institute for Clinical and Economic Review (ICER).

FDA 59

FDA 59

pharmaphorum

NOVEMBER 27, 2022

Supply chain issues have been rife in pharmaceuticals for a while, but current socio-economic challenges such as the conflict in Ukraine and the COVID-19 pandemic have led to extended wait times and higher prices for thousands of products.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies Packaging 105

Pharmaceutical Technology

APRIL 5, 2023

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. There are issues of geography, but also issues of economics. Currently, all approved CAR-T therapies are autologous, where T cells taken from patients are modified and then re-infused.

FDA 59

FDA Immunization 59

Pharmaceutical Technology

JUNE 21, 2023

The high price tag may be hard to defend , but with lifetime treatment costs for haemophilia B reaching as high as $23m for some, the single-dose treatment could prove far more cost-effective. Despite this, the Institute for Clinical and Economic Review (ICER) claimed that a fairer price would be in the region of $2.9m.

FDA 98

FDA 98

Pharma Marketing Network

JUNE 8, 2020

Unfortunately, having had ten friends my age or younger die by the time I was 40 gave me a very unique look into health care and some of the devastating impacts of it. We are now in a 20-yearlong economic depression for the working and middle class as a result of health care prices inflating, prices not cost.

Health and Personal Care Stores 40

Health and Personal Care Stores Hospitals Mayo Clinic Specialty Pharmacies 40